{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:15:44Z","timestamp":1761059744752},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T00:00:00Z","timestamp":1402444800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00259-014-2819-2","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T23:30:59Z","timestamp":1402443059000},"page":"1666-1672","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Relationship between quantitative cardiac neuronal imaging with 123I-meta-iodobenzylguanidine and hospitalization in patients with heart failure"],"prefix":"10.1007","volume":"41","author":[{"given":"Matthew W.","family":"Parker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitesh","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan W.","family":"Ahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold F.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary V.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin B.","family":"Lundbye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,11]]},"reference":[{"key":"2819_CR1","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics \u2013 2013 update: a report from the American Heart Association. Circulation. 2013;127:e6\u2013245.","journal-title":"Circulation"},{"key":"2819_CR2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jacc.2008.11.009","volume":"53","author":"M Jessup","year":"2009","unstructured":"Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Graniats TG, et al. 2009 focused update: ACCF\/AHA guidelines for the diagnosis and management of heart failure in adults. J Am Coll Cardiol. 2009;53:1343\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"2819_CR3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1161\/CIRCOUTCOMES.110.958009","volume":"4","author":"LA Allen","year":"2011","unstructured":"Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, et al. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011;4:389\u201398.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2819_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10741-011-9256-0","volume":"17","author":"M Zaya","year":"2012","unstructured":"Zaya M, Phan A, Schwarz ER. The dilemma, causes and approaches to avoid recurrent hospital readmissions for patients with chronic heart failure. Heart Fail Rev. 2012;17:345\u201353.","journal-title":"Heart Fail Rev"},{"key":"2819_CR5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819\u201323.","journal-title":"N Engl J Med"},{"key":"2819_CR6","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1053\/euhj.2000.2407","volume":"22","author":"HP Brunner-La Rocca","year":"2001","unstructured":"Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J. 2001;22:1136\u201343.","journal-title":"Eur Heart J"},{"key":"2819_CR7","first-page":"96","volume":"1","author":"JC Sisson","year":"1986","unstructured":"Sisson JC, Wieland DM. Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am J Physiol Imaging. 1986;1:96\u2013103.","journal-title":"Am J Physiol Imaging"},{"key":"2819_CR8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00259-006-0359-0","volume":"34","author":"S Yamashina","year":"2007","unstructured":"Yamashina S, Yamazaki J-I. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging. 2007;34:939\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2819_CR9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","volume":"29","author":"HJ Verberne","year":"2008","unstructured":"Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147\u201359.","journal-title":"Eur Heart J"},{"key":"2819_CR10","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","volume":"55","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. J Am Coll Cardiol. 2010;55:2212\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"2819_CR11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12350-008-9008-2","volume":"16","author":"AF Jacobson","year":"2009","unstructured":"Jacobson AF, Lombard J, Banerjee G, Camici PG. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials. J Nucl Cardiol. 2009;16:113\u201321.","journal-title":"J Nucl Cardiol"},{"key":"2819_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12350-011-9438-0","volume":"19","author":"J Chen","year":"2012","unstructured":"Chen J, Folks RD, Verdes L, Manatunga DN, Jacobson AF, Garcia EV. Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake. J Nucl Cardiol. 2012;19:92\u20139.","journal-title":"J Nucl Cardiol"},{"key":"2819_CR13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJMoa020233","volume":"347","author":"AS Maisel","year":"2002","unstructured":"Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161\u20137.","journal-title":"N Engl J Med"},{"key":"2819_CR14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jech.2004.030759","volume":"59","author":"JW Twisk","year":"2005","unstructured":"Twisk JW, Smidt N, de Vente W. Applied analysis of recurrent events: a practical overview. J Epidemiol Community Health. 2005;59:706\u201310.","journal-title":"J Epidemiol Community Health"},{"key":"2819_CR15","unstructured":"Cleves M. STATA Manual. StataCorp; 1999. Available from: http:\/\/www.stata.com\/support\/faqs\/statistics\/multiple-failure-time-data\/ ."},{"key":"2819_CR16","first-page":"155","volume":"45","author":"M Kyuma","year":"2004","unstructured":"Kyuma M, Nakata T, Hashimoto A, Nagao K, Sasao H, Takahashi T, et al. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure. J Nucl Med. 2004;45:155\u201363.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"2819_CR17","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1007\/s00259-007-0442-1","volume":"34","author":"R Lautam\u00e4ki","year":"2007","unstructured":"Lautam\u00e4ki R, Tipre D, Bengel FM. Cardiac sympathetic neuronal imaging using PET. Eur J Nucl Med Mol Imaging. 2007;34 Suppl 1:S74\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2819_CR18","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.nuclcard.2007.08.004","volume":"14","author":"SA Nishioka","year":"2007","unstructured":"Nishioka SA, Martinelli Filho M, Brand\u00e3o SC, Giorgi MC, Vieira ML, Costa R, et al. Cardiac sympathetic activity pre and post resynchronization therapy evaluated by 123I-MIBG myocardial scintigraphy. J Nucl Cardiol. 2007;14:852\u20139.","journal-title":"J Nucl Cardiol"},{"key":"2819_CR19","first-page":"845","volume":"41","author":"D Agostini","year":"2000","unstructured":"Agostini D, Belin A, Amar MH, Darlas Y, Hamon M, Grollier G, et al. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. J Nucl Med. 2000;41:845\u201351.","journal-title":"J Nucl Med"},{"key":"2819_CR20","first-page":"1279","volume":"43","author":"S Kasama","year":"2002","unstructured":"Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, et al. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure. J Nucl Med. 2002;43:1279\u201385.","journal-title":"J Nucl Med"},{"key":"2819_CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0002-8703(97)70232-1","volume":"133","author":"M Suwa","year":"1997","unstructured":"Suwa M, Otake Y, Moriguchi A, Ito T, Hirota Y, Kawamura K, et al. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. Am Heart J. 1997;133:353\u20138.","journal-title":"Am Heart J"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-014-2819-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-014-2819-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:06:19Z","timestamp":1558713979000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-014-2819-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,11]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2819"],"URL":"https:\/\/doi.org\/10.1007\/s00259-014-2819-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,11]]}}}